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Abstract
Objectives To determine the accuracy of a clinical decision rule (the
traffic light system developed by the National Institute for Health and
Clinical Excellence (NICE)) for detecting three common serious bacterial
infections (urinary tract infection, pneumonia, and bacteraemia) in young
febrile children.
Design Retrospective analysis of data from a two year prospective
cohort study
Setting A paediatric emergency department.
Participants 15 781 cases of children under 5 years of age presenting
with a febrile illness.
Main outcome measures Clinical features were used to categorise
each febrile episodes as low, intermediate, or high probability of serious
bacterial infection (green, amber, and red zones of the traffic light
system); these results were checked (using standard radiological and
microbiological tests) for each of the infections of interest and for any
serious bacterial infection.
Results After combination of the intermediate and high risk categories,
the NICE traffic light system had a test sensitivity of 85.8% (95%
confidence interval 83.6% to 87.7%) and specificity of 28.5% (27.8% to
29.3%) for the detection of any serious bacterial infection. Of the 1140
cases of serious bacterial infection, 157 (13.8%) were test negative (in
the green zone), and, of these, 108 (68.8%) were urinary tract infections.
Adding urine analysis (leucocyte esterase or nitrite positive), reported
in 3653 (23.1%) episodes, to the traffic light system improved the test
performance: sensitivity 92.1% (89.3% to 94.1%), specificity 22.3%
(20.9% to 23.8%), and relative positive likelihood ratio 1.10 (1.06 to
1.14).
Conclusion The NICE traffic light system failed to identify a substantial
proportion of serious bacterial infections, particularly urinary tract
infections. The addition of urine analysis significantly improved test
sensitivity, making the traffic light system a more useful triage tool for
the detection of serious bacterial infections in young febrile children.
Introduction
Febrile illnesses are one of the most common reasons for young
children to present to primary care practitioners andmay account
for up to a third of presentations to emergency departments.1-3
Depending on the setting, about 5–25% of fever episodes in
young children are due to serious bacterial infections.4-10 If not
detected and managed in a timely manner, such infections may
lead to complications, long term disability, and even death.11 12
Young children and infants with serious bacterial infection may
manifest few, if any, localising signs of systemic infection.13-15
A key challenge for physicians in the clinical evaluation of
febrile young children is being able to correctly triage febrile
illnesses, identifying those likely to be due to serious bacterial
infections in a timely manner while at the same time avoiding
over-investigation and overmedication of children, most of
whom will have self limiting viral illnesses.
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Several clinical criteria and decision tools have been developed
to assist clinicians in identifying which febrile children have a
serious illness. Unfortunately these have either not been
externally validated in independent datasets, do not perform
consistently, have insufficient accuracy, or apply only to a
limited age range.8 16-20 Recently the UK National Institute for
Health and Clinical Excellence (NICE) published a guideline
which provides a traffic light system for the initial assessment
and management of young children with fever.21 The NICE
traffic light system was designed for young children under 5
years of age and was intended for a range of settings (general
practice, paediatric specialists, or remote assistance by health
professionals), and is a colour coded checklist of symptoms and
signs (see online supplementary table 1 on bmj.com). Children
whose clinical features fall within the green zone are considered
to be at low risk of serious illness, while those in the amber and
red zones are at intermediate and high risk respectively. The
NICE guidance recommends that further investigations be
directed according to the level of risk (see online supplementary
table 2 on bmj.com). Although it has been widely promulgated,
the accuracy of this system for the detection of serious bacterial
infections has not been validated to date.
The aims of our study were to determine the test performance
of the NICE traffic light system for the detection of three of the
most common serious bacterial infections in young febrile
children—urinary tract infection, pneumonia, and
bacteraemia—and to assess whether the addition of urine
analysis, a near patient test with good performance
characteristics,22 improves the performance of the NICE traffic
light system. For this study we used data collected prospectively
for the Febrile Evaluation of Children in the Emergency Room
(FEVER) study.23 The FEVER study (conducted between July
2004 and June 2006) preceded the NICE fever guideline
(published in May 2007).
Methods
Study design and setting
Details of the main FEVER study are reported elsewhere.23 We
incorporated the Standard for Reporting of Diagnostic Accuracy
(STARD) guidelines for study reporting.24
Recruitment
Consecutive children under 5 years old who presented with a
febrile illness to the emergency department of the Children’s
Hospital at Westmead between 1 July 2004 and 30 June 2006
were eligible. Febrile illness was defined as any illness that met
one or more of the following criteria: a measured axillary
temperature ≥38.0°C; parental report of a temperature ≥38.0°C
measured at home within the previous 24 hours; parental report
that the child “felt hot” in the previous 24 hours; and a
presenting problem related to fever (10th revision of the
international classification of diseases, Australian modification
codes R50, R50.0, R50.1. R50.9 and R 56.0), as determined by
a triage nurse.
The unit of analysis was an instance of febrile illness. In the
case of multiple presentations with the same illness, history and
clinical evaluation data from the first visit only were used. Case
definition for “same illness” was if the child presented within
24 hours of a previous visit or if the fever had persisted between
visits to the emergency department without a fever-free period
of at least 24 hours.
Study exclusion criteria
Children transferred from another hospital, those with
malignancy, and transplant recipients were excluded.
Data collection
Each child was triaged at presentation to the emergency
department using the Australasian triage scale. This scale
consists of five categories based on the level of clinical urgency,
with cases assigned to category one being the most urgent and
cases assigned to category five being the least urgent.25 Clinical
information for each illness episode was recorded by the
examining physician (emergency department physician,
paediatric trainee, or emergency medicine trainee) into a
mandatory template within the hospital’s electronic record
keeping system. This ensured a standardised assessment with
entry of 40 clinical features (symptoms and signs) and relevant
backgroundmedical information of the children for each episode
of febrile illness. The template was completed after the initial
physician assessment but before test results were obtained. Any
tests ordered (including urine analysis) were at the discretion
of the treating physician. Test results, emergency department
diagnoses, and admission details were electronically linked to
the research database.
Outcome definitions
The primary outcomes of interest were the three most common
serious bacterial infections in young children with
fever—urinary tract infection, pneumonia, and bacteraemia.
There were too few cases of other forms of serious bacterial
infection, such as meningitis, osteomyelitis, and septic arthritis,
to provide robust estimates of the performance of the traffic
light system for these infections separately. We included these
illnesses in a fourth category, “any serious bacterial infection,”
in combination with the three common infections. In cases where
multiple infections clustered together—for example, when a
child developed concomitant urinary tract infection and
bacteraemia—they were included in all relevant outcomes.
Reference standard test criteria for the diagnosis of serious
bacterial infection included culture positivity (for urinary tract
infection and bacteraemia) or radiological criteria (for
pneumonia) and are detailed elsewhere.23
Follow-up
All eligible children were followed up until they fulfilled the
case definition for serious bacterial infection or until the fever
had resolved for over 24 hours. Follow-up was undertaken at
10–14 days after the emergency department visit. Hospital
records were reviewed, and parental reports (via telephone call
follow-up) of resolution of fever, antibiotic use, and attendance
at other healthcare facilities were obtained. Copies of test reports
and chest x ray films from other healthcare facilities were
obtained with parental consent.
Applying the NICE traffic light system
Wematched the items comprising the NICE traffic light system
to equivalent items within the FEVER study febrile template
(see supplementary table 3 on bmj.com), which allowed us to
apply the system retrospectively to each febrile episode in the
FEVER study cohort. Accordingly, each episodewas categorised
as having a low, intermediate, or high probability of serious
bacterial infection based on whether their clinical features fitted
in the green, amber, or red zones of the NICE traffic light
system. This was then compared with the final diagnosis as
determined by reference standard test results and follow-up.
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Urine analysis
Urine analysis was done at presentation to the emergency
department by the attending doctor or nurse in some children.
The urine collection method was in accordance with local
clinical practice and was not specified for the study. The urine
analysis result was reported semi-quantitatively based on the
test strip reference chart. For the purpose of our study, the
presence of any level of nitrite or leucocyte esterase was
considered as test positive.
Statistical analysis
For each of the four infection categories (urinary tract infection,
bacteraemia, pneumonia, and any serious bacterial infection),
sensitivity and specificity were calculated for two thresholds
for test positivity (presence of one or more red zone features
versus one or more red or amber zone features). These cut points
are displayed graphically with a receiver operating
characteristics curve. For the subgroup of children who had a
urine analysis reported, we reassessed the test performance of
the traffic light system with and without the urine analysis
results. We investigated four thresholds for positive urine
analysis: leucocyte esterase positive, nitrite positive, either
leucocyte esterase or nitrite positive, and both leucocyte esterase
and nitrite positive.
We compared the incremental gain in performance of the NICE
traffic lights with the combination of the NICE traffic lights
and urine analysis (test positive defined as presence of any one
or more of the following: amber traffic light features, red traffic
light features, leucocyte esterase positive in urine, nitrite positive
in urine). Because of the expected trade-off in test sensitivity
and specificity when adding a test, we assessed the incremental
gain through the relative positive likelihood ratio of the
combination of the NICE traffic lights and urine analysis, to the
NICE traffic lights on its own.26 27We obtained 95% confidence
intervals for the relative positive likelihood ratios; if the relative
positive likelihood ratio is greater than 1 and its confidence
interval does not include 1, the combined test has superior
performance than the NICE traffic light system on its own.26
An increase in the positive likelihood ratio would result in an
increase in the positive predictive value of the test—that is, the
probability of infection given a positive test result.
Results
During the study period there were 19 889 visits by febrile
children under 5 years of age. Patient flow in the FEVER study
is detailed in figure 1⇓. Overall, 15 781 eligible febrile illnesses
were included in our analysis, 1120 (7.1%) due to serious
bacterial infection, with 1166 infections identified; urinary tract
infection in 543 (3.4% of the 15 781), pneumonia in 533 (3.4%),
bacteraemia in 64 (0.4%), osteomyelitis in 12 (0.08%),
meningitis in 8 (0.05%), and septic arthritis in 6 (0.04%).
Multiple infections per illness occurred uncommonly, with 44
of the 1120 (3.9%) due to two or more serious bacterial
infections (two infections in 42 illnesses, and three infections
in two illnesses).
Characteristics of included children and
illnesses (table 1 )
Over a quarter of the illness episodes were in children under 1
year old, and almost half were in children aged between 1 and
3 years. Hospitalisation was required in 1912 (12.1%) fever
episodes. Four hundred (82.8%) of the 483 febrile illnesses that
received a triage category of one or two were in the NICE red
zone. Among those receiving a triage category of three,
2371/4894 (48.4%) were in the red zone, while 1042/6936
(15.0%) with a triage category of four and 253/3468 (7.3%)
with a triage category of five were in the red zone. Viral
infection, viral upper respiratory tract infection, and
gastroenteritis were the most common clinical diagnoses.
A dipstick urine analysis was performed in 3653 (23.1%) of the
15781 febrile illnesses. Urine collection method was recorded
for only 2262 samples sent for urine culture. Of these 2262
samples, the in-out catheter method was used in 1022 (45.2%),
a clean catch specimen in 691 (30.5%), mid-stream sample in
519 (22.9%), supra-pubic aspirate in 10 (0.4%), and a bag
specimen in 20 (0.9%). The proportion of children who had
urine analysis is detailed by patient characteristics in
supplementary table 4 on bmj.com. Children who were more
unwell (triage categories one and two), who required
hospitalisation, or had higher temperatures at presentation were
more likely to have a urine analysis. A greater proportion of
children with a provisional diagnosis of fever with no focus had
a urine analysis done than children with a provisional diagnosis
of asthma, croup, bronchiolitis, pneumonia, or a focal bacterial
infection.
Concordance between NICE traffic light
system and the FEVER data fields
Nearly three quarters of the 43 items listed in the traffic light
system had comparable fields in the FEVER study. Thirteen
(30%) of the 43 symptoms and signs had an exact match in
FEVER, while 19 (44%) symptoms and signs were captured by
similarly phrased terminology in the FEVER dataset
(supplementary table 3 on bmj.com). Eleven (26%) of the 43
symptoms and signs listed in the traffic light system did not
have an equivalent field in the fever dataset. These mostly
included items such as “a new lump,” “swelling of a limb or
joint,” “non-weight bearing limb,” and “bile stained vomit.”
Given that these are relatively specific clinical indicators for
hernia, focal bone or joint pathology, and bowel obstruction
respectively, it is unlikely that the absence of data relating to
these would alter the performance of the traffic light system for
the detection of urinary tract infections, bacteraemia, or
pneumonia, which are the outcomes of interest for this study.
Test performance of NICE traffic light system
for detection of bacteraemia, urinary tract
infection, and pneumonia
Combining the intermediate and high risk traffic light categories
(presence of features that were in the amber or red zones) gave
a test sensitivity of 85.8% (95% confidence interval 83.6% to
87.7%) and specificity of 28.5% (27.8% to 29.3%) for the
detection of any serious bacterial infection. The high risk
category (presence of one or more feature in the red zone) had
a sensitivity of 47.9% (44.9% to 50.8%) and specificity of 75.9%
(75.2% to 76.6%). Among the serious bacterial infections,
40/533 (7.5%) cases of pneumonia, 9/64 (14.1%) cases of
bacteraemia, and 108/543 (19.9%) cases of urinary tract
infections were in the green zone and would be missed using
the NICE traffic light system.
Urine analysis had been reported in 3653 (23.1%) of the 15 781
febrile episodes. In this subset, 492 febrile episodes had a final
diagnosis of one or more serious bacterial infection (362 urinary
tract infections, 118 cases of pneumonia, and 27 cases of
bacteraemia). Threshold specific sensitivities and specificities
for the combination of the traffic light systemwith urine analysis
are detailed in table 2⇓. For the detection of urine tract
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infections, the combined test had improved performance over
the NICE traffic light system on its own (fig 2⇓), with a relative
positive likelihood ratio of 1.17 (95% confidence interval 1.12
to 1.23). For the detection of any serious bacterial infection, the
relative positive likelihood ratio was 1.10 (1.06 to 1.14), also
indicating improved performance of the combined test over the
NICE traffic light system.
Discussion
We found that the NICE traffic light system has moderate
sensitivity but low specificity for detection of the three most
common serious bacterial infections in febrile young children,
namely bacteraemia, urinary tract infections, and pneumonia.
Importantly the traffic light systemmissed a sizeable proportion
of urinary tract infections. This is a substantial deficiency in a
screening tool for serious bacterial infections in febrile young
children, given that, after the introduction of pneumococcal
conjugate vaccine, the prevalence of occult bacteraemia in
febrile children presenting to emergency departments has
decreased substantially to somewhere between 0.4% and 0.7%,28
whereas the prevalence of urinary tract infection in children
with fever without a clinically obvious source remains greater
than 7%.29 Adding urine analysis, a simple and inexpensive
near-patient test, to the traffic light system led to an appreciable
increase in the proportion of urinary tract infections detected,
and a concomitant increase in the overall proportion of serious
bacterial infections detected.
The NICE fever guidelines advise routine testing of urine in all
children with fever without apparent source (including those
who are in the green zone of the traffic light system), thus
helping to avoid missed cases of urinary tract infections, but
they do not include this test in the traffic light system itself.21 30
Based on our findings, we strongly support this recommendation
but suggest that urine analysis be added to the traffic light
criteria. We recommend that urine analysis should be done
routinely in children with fever and suspected bacterial infection
and only children with a negative result should be classified as
belonging to the green (low infection risk) zone. However,
although such an addition would improve the discriminatory
ability of the NICE traffic light system, clinicians who use this
approach should be aware of the appreciable number of
misclassified children that remain. In our subset that had urine
analysis (n=3653), the traffic light system with urine analysis
included had a 78.0% (2466/3161) false positive rate (over three
quarters of illness episodes that were not due to a serious
bacterial infection were test positive) and 8.1% false negative
rate (40/492 of illness episodes due to serious bacterial infections
were test negative). Given its low test specificity, clinicians
must still judge each case based on its individual features to
avoid over-investigation and overtreatment.
Comparison with other studies
To our knowledge, only one other study has evaluated the test
performance of the NICE traffic light system. This was done in
700 children aged between 3months and 16 years with suspected
acute infection.31 In that study the traffic light system had a
reported test sensitivity of 85% and specificity of 29% for
detection of illnesses (bacterial or non-bacterial in origin) that
were considered to be serious or of intermediate severity
(uncomplicated urinary tract infections were classified as being
mild in severity). However, the number of children with an
infection that was reported as serious or of intermediate severity
was relatively low (313 in total, with only 67 cases of pneumonia
with radiological confirmation, five cases of bacteraemia, and
30 urinary tract infections with systemic symptoms), and so test
performance metrics were relatively imprecise. The study also
included children up to 16 years old (median age 3 years),
although the NICE traffic light systemwas designed for children
up to 5 years old. Finally, the validity of these findings is
uncertain because the reference standard test for illness severity
was the unverified final diagnoses made by the treating
physicians and not standard, microbiologically based definitions.
The authors of that study acknowledge that they did not have
data on all the “red” and “amber” features.
Strengths and limitations of study
Ours is the first study that has evaluated the test accuracy of the
NICE traffic light system for the detection of serious bacterial
infections in febrile children under 5 years old, for whom this
test was intended, but it does have limitations. The data were
not collected for this purpose, and so there was incomplete
overlap between the clinical criteria in the NICE traffic light
system and FEVER data fields. However, most of the clinical
criteria required for the traffic light system—especially all the
common criteria relevant to the evaluation of possible urinary
tract infection, bacteraemia, and pneumonia—were captured by
the corresponding FEVER data fields. We believe that the lack
of fields in the FEVER data corresponding to NICE fields such
as “a new lump,” “swelling of a limb or joint,” “not weight
bearing,” and “bile stained vomit” is unlikely to have affected
the detection of the serious bacterial infections of interest to any
significant extent, although these could well be of relevance
when assessing for other serious infections or illnesses such as
septic arthritis, osteomyelitis, or bowel obstruction. A second
limitation was that the FEVER study had small numbers of
serious bacterial infections other than urinary tract infection,
bacteraemia, and pneumonia. As such, the validity of the NICE
traffic light system for detection of other serious bacterial
infections (such as meningitis, osteomyelitis, and septic arthritis)
could not be assessed with confidence. However, the small
number of cases of these infections in our study reflects the low
prevalence of these infections in a setting of a developed country
where immunisation is almost universal.
Our evaluation of the test performance of the traffic light system
with the addition of urine analysis was potentially limited by
the fact that only about a quarter of the FEVER cohort had a
urine analysis. The decision to perform a urine analysis was at
the treating clinician’s discretion. As expected, the group of
children who had urine analysis was at higher risk of urinary
tract infection, and were different than those who did not have
a urine analysis performed. This reflects standard clinical
practice, where it is not routine to subject a young child with
an obvious focus of infection as the fever source and who is at
low risk of urinary tract infection to a potentially invasive test.
Mandating a urine culture in all eligible children was not
ethically justifiable. However, this may lead to verification bias,
where only those who are positive for the index test (in this case
the traffic light system, with or without the urine analysis), have
the reference standard test performed (urine culture), leading
to overestimates of test sensitivity. Although possible in our
study, this bias may have been ameliorated because the traffic
light system was not designed when the FEVER study was
conducted, and so could not have been used to determine which
children should have had a urine culture performed. Further,
the design of our study required that all children were followed
until the febrile illness resolved (two step verification process),
which was achieved in 93% of all illnesses. Finally, even with
a potentially optimistic estimate of sensitivity for the traffic
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light system, our study shows that improvements in performance
are required, such as the inclusion of the urine analysis result.
It could be argued that the NICE guidance was designed to
detect all serious illnesses, not just infections. The definition of
serious illness in the NICE guidance was “an illness with fever
that could cause death or disability if there was a delay in
diagnosis or treatment.”While this definition would be inclusive
of serious bacterial infections, it also implies detection of serious
illnesses that are not of bacterial origin such as Kawasaki
disease, viral gastroenteritis with moderate or severe
dehydration, metabolic conditions presenting with acid-base or
electrolyte imbalance, or severe viral lower respiratory tract
infections requiring supportive management. We assessed the
accuracy of the traffic light system only for detecting serious
bacterial infections and thus did not explore the full potential
of this clinical tool. We also did not attempt to assess its clinical
effectiveness or ease of application, nor clinicians’ willingness
to use it.
Conclusions
The NICE traffic light system has moderate test sensitivity but
low specificity for the detection of the three most common
serious bacterial infections in young febrile children. The system
missed a substantial proportion of urinary tract infections, but
the addition of urine analysis improved performance
significantly, as reflected in the relative positive likelihood ratio.
With the addition of this relatively simple, non-invasive, and
inexpensive near patient test, the traffic light system may be a
useful triage tool for healthcare professionals for the initial
evaluation of likelihood of serious bacterial infections in young
febrile children. Clinical effectiveness and acceptability of the
system for the detection of serious illnesses need to be assessed
through randomised control trials.
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What is already known on this topic
Diagnosis of serious bacterial infections in young children with febrile illnesses is challenging
The NICE guidelines on febrile illnesses in children provide a simple clinical tool (a traffic light system) to guide healthcare professionals’
initial assessment of febrile children, but the accuracy of the tool for detecting serious bacterial infections in young children has not been
tested
What this study adds
The NICE traffic light system has a moderate sensitivity and low specificity for detection of serious bacterial infections, and urinary tract
infections in particular tend to go undetected with the system
Adding urine analysis to the traffic light system enhances its sensitivity substantially and increases its positive predictive value, making
it a potentially useful tool for the initial evaluation of febrile infants and young children.
The low test specificity of the traffic light system makes individual case based clinical judgement critical for clinicians to avoid
overinvestigation and unnecessary hospitalisation or treatment
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Tables
Table 1| Characteristics of the study population






























2125 (13.5)Asthma, croup, bronchiolitis
1586 (10.1)Focal infections†
1285 (8.1)Fever no focus
641 (4.1)Pneumonia
420 (2.7)Febrile convulsion






974 (6.2)All other diagnoses
*Triage categories are as per the Australasian triage scale.
†Lymphadenitis, tonsillitis, otitis media, or cellulitis.
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Table 2| Performance of the NICE traffic light system with and without urine analysis for detection of serious bacterial infections. Values
are percentages (95% confidence intervals)
Traffic light with urine analysis†
Traffic light only









85.8 (82.4 to 88.6)86.6 (83.3 to 89.3)91.3 (88.4 to 93.4)92.1 (89.3 to 94.1)80.7 (76.9 to 83.9)Sensitivity
24.8 (23.3 to 26.3)24.6 (23.1 to 26.1)22.5 (21.1 to 23.9)22.3 (20.9 to 23.8)25.0 (23.5 to 26.5)Specificity
Urinary tract infection:
85.4 (81.3 to 88.6)86.5 (82.6 to 89.6)92.8 (89.7 to 95.1)93.9 (90.9 to 95.9)78.5 (73.9 to 82.4)Sensitivity
24.4 (22.9 to 25.9)24.2 (22.8 to 25.7)22.1 (20.7 to 23.5)21.9 (20.5 to 23.4)24.5 (23.1 to 25.9)Specificity
Bacteraemia:
81.5 (63.3 to 91.8)81.5 (63.3 to 91.8)81.5 (63.3 to 91.8)81.5 (63.3 to 91.8)81.5(63.3 to 91.8)Sensitivity
23.4 (22.0 to 24.8)23.2 (21.8 to 24.6)20.6 (19.3 to 21.9)20.4 (19.1 to 21.8)24.3 (22.9 to 25.7)Specificity
Pneumonia:
88.9 (82.1 to 93.4)88.9 (82.1 to 93.4)88.9 (82.1 to 93.4)88.9 (82.1 to 93.4)88.9 (82.1 to 93.4)Sensitivity
23.8 (22.4 to 25.2)23.5 (22.1 to 24.9)20.9 (19.6 to 22.3)20.7 (19.4 to 22.1)24.7 (23.3 to 26.1)Specificity
*Presence of any one or more serious bacterial infection.
†Test positive is presence of amber or red traffic light feature, or positive urine analysis, or both.
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Figures
Fig 1 Patient flow chart
Fig 2 Receiver operating characteristics curve for performance of the NICE traffic light system, with or without the addition
of urine analysis, for detection of serious bacterial infections
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